Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Reevaluation of the efficacy of favipiravir against rabies virus using in vivo imaging analysis.

Yamada K, Noguchi K, Kimitsuki K, Kaimori R, Saito N, Komeno T, Nakajima N, Furuta Y, Nishizono A.

Antiviral Res. 2019 Dec;172:104641. doi: 10.1016/j.antiviral.2019.104641. Epub 2019 Oct 28.

PMID:
31672666
2.

Vascular Leak and Hypercytokinemia Associated with Severe Fever with Thrombocytopenia Syndrome Virus Infection in Mice.

Westover JB, Hickerson BT, Van Wettere AJ, Hurst BL, Kurz JP, Dagley A, W├╝lfroth P, Komeno T, Furuta Y, Steiner T, Gowen BB.

Pathogens. 2019 Sep 21;8(4). pii: E158. doi: 10.3390/pathogens8040158.

3.

Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration.

Tani H, Komeno T, Fukuma A, Fukushi S, Taniguchi S, Shimojima M, Uda A, Morikawa S, Nakajima N, Furuta Y, Saijo M.

PLoS One. 2018 Oct 26;13(10):e0206416. doi: 10.1371/journal.pone.0206416. eCollection 2018.

4.

Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice.

Hawman DW, Haddock E, Meade-White K, Williamson B, Hanley PW, Rosenke K, Komeno T, Furuta Y, Gowen BB, Feldmann H.

Antiviral Res. 2018 Sep;157:18-26. doi: 10.1016/j.antiviral.2018.06.013. Epub 2018 Jun 21.

PMID:
29936152
5.

Use of Favipiravir to Treat Lassa Virus Infection in Macaques.

Rosenke K, Feldmann H, Westover JB, Hanley PW, Martellaro C, Feldmann F, Saturday G, Lovaglio J, Scott DP, Furuta Y, Komeno T, Gowen BB, Safronetz D.

Emerg Infect Dis. 2018 Sep;24(9):1696-1699. doi: 10.3201/eid2409.180233. Epub 2018 Sep 17.

6.

Favipiravir (T-705) protects against Nipah virus infection in the hamster model.

Dawes BE, Kalveram B, Ikegami T, Juelich T, Smith JK, Zhang L, Park A, Lee B, Komeno T, Furuta Y, Freiberg AN.

Sci Rep. 2018 May 15;8(1):7604. doi: 10.1038/s41598-018-25780-3.

7.

Effective Treatment of Experimental Lymphocytic Choriomeningitis Virus Infection: Consideration of Favipiravir for Use With Infected Organ Transplant Recipients.

Hickerson BT, Westover JB, Jung KH, Komeno T, Furuta Y, Gowen BB.

J Infect Dis. 2018 Jul 13;218(4):522-527. doi: 10.1093/infdis/jiy159.

8.

Enhanced protection against experimental Junin virus infection through the use of a modified favipiravir loading dose strategy.

Gowen BB, Westover JB, Sefing EJ, Van Wettere AJ, Bailey KW, Wandersee L, Komeno T, Furuta Y.

Antiviral Res. 2017 Sep;145:131-135. doi: 10.1016/j.antiviral.2017.07.019. Epub 2017 Aug 2.

9.

Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase.

Furuta Y, Komeno T, Nakamura T.

Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(7):449-463. doi: 10.2183/pjab.93.027. Review.

10.

Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis.

Yamada K, Noguchi K, Komeno T, Furuta Y, Nishizono A.

J Infect Dis. 2016 Apr 15;213(8):1253-61. doi: 10.1093/infdis/jiv586. Epub 2015 Dec 9.

11.

The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.

Safronetz D, Rosenke K, Westover JB, Martellaro C, Okumura A, Furuta Y, Geisbert J, Saturday G, Komeno T, Geisbert TW, Feldmann H, Gowen BB.

Sci Rep. 2015 Oct 12;5:14775. doi: 10.1038/srep14775.

12.

Aralin, a type II ribosome-inactivating protein from Aralia elata, exhibits selective anticancer activity through the processed form of a 110-kDa high-density lipoprotein-binding protein: a promising anticancer drug.

Otsuka H, Gotoh Y, Komeno T, Ono T, Kawasaki Y, Iida N, Shibagaki Y, Hattori S, Tomatsu M, Akiyama H, Tashiro F.

Biochem Biophys Res Commun. 2014 Oct 10;453(1):117-23. doi: 10.1016/j.bbrc.2014.09.067. Epub 2014 Sep 26.

PMID:
25261720
13.

Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase.

Sangawa H, Komeno T, Nishikawa H, Yoshida A, Takahashi K, Nomura N, Furuta Y.

Antimicrob Agents Chemother. 2013 Nov;57(11):5202-8. doi: 10.1128/AAC.00649-13. Epub 2013 Aug 5.

14.

An apoptotic inducer, aralin, is a novel type II ribosome-inactivating protein from Aralia elata.

Tomatsu M, Kondo T, Yoshikawa T, Komeno T, Adachi N, Kawasaki Y, Ikuta A, Tashiro F.

Biol Chem. 2004 Sep;385(9):819-27.

PMID:
15493877

Supplemental Content

Loading ...
Support Center